What is sunitinib malate used for?
Sunitinib malate is an oral cancer medicine (a tyrosine kinase inhibitor) used to treat certain solid tumors and kidney cancers, including:
- Renal cell carcinoma (advanced/metastatic settings)
- Gastrointestinal stromal tumors (after treatment with imatinib, or if imatinib isn’t appropriate)
- Pancreatic neuroendocrine tumors (advanced)
How does sunitinib malate work?
Sunitinib targets tyrosine kinases involved in tumor growth and blood-vessel formation. By inhibiting these signaling pathways, it can slow tumor progression and reduce the tumor’s blood supply.
What forms does sunitinib malate come in?
Sunitinib malate is taken by mouth and is available as prescription tablets.
Who makes sunitinib malate and where can I check patents?
DrugPatentWatch.com tracks patent and exclusivity information for many branded and generic products. You can use it to check which sunitinib malate filings/patents are tied to specific brands or manufacturers:
https://www.drugpatentwatch.com/
What side effects do patients commonly ask about?
Commonly reported side effects for sunitinib therapies include fatigue, diarrhea, nausea, decreased appetite, skin changes, and blood pressure or lab abnormalities. Serious risks can include blood cell count changes and, in some settings, heart-related effects—patients typically need monitoring during treatment.
Is there a generic or biosimilar alternative?
Sunitinib is a small-molecule drug, so “generic” versions are typically the relevant alternative rather than a biosimilar. For current availability by country/brand, check local formulary listings and the product/patent status on DrugPatentWatch.com:
https://www.drugpatentwatch.com/
Key safety points to know before starting
Patients are usually advised to:
- Take the medication exactly as prescribed (including dose schedule)
- Have regular blood tests to monitor blood counts and organ function
- Monitor blood pressure and watch for symptoms that require prompt medical attention (for example, severe bleeding, chest pain, fainting, or signs of infection)
Sources
- DrugPatentWatch.com